PMID: 20126852Feb 4, 2010Paper

Evaluation of late-onset hypogonadism (andropause) treatment using three different formulations of injectable testosterone

Arquivos brasileiros de endocrinologia e metabologia
Alexandre HohlRoger Walz

Abstract

To compare the modalities of treatment for male hypogonadism available in Brazil. Thirty-two men with late-onset hypogonadism ('andropause') were followed-up in the Hospital de Guarnição de Florianópolis, in Florianópolis, south Brazil. Clinical diagnosis was established according to AMS questionnaire (positive if equal to or higher than 27 points), and laboratory diagnosis was made through low values of total testosterone (under 300 ng/dL) and/or free calculated testosterone (under 6.5 ng/dL). Patients were randomized to three non-enteral treatment groups (Deposteron--11 patients; Durateston--11 patients; and Nebido--10 patients). Clinically, Nebido seemed to be superior when compared to Deposteron (mean value of improvement percentage; p = 0.03) and when compared to Durateston (post-treatment average AMS score; p = 0.03). According to laboratory analysis, Nebido showed higher testosterone levels than Deposteron and Durateston (p < 0.001). All non-enteral testosterone formulas available in the Brazilian market are efficient in raising testosterone levels and in clinical improvement of hypogonadal patients. Nebido showed both a better clinical and laboratory effectiveness.

References

Apr 22, 1992·JAMA : the Journal of the American Medical Association·H B CarterP C Walsh
Nov 1, 1991·The Journal of Clinical Endocrinology and Metabolism·A GrayC Longcope
Dec 1, 1980·The Journal of Clinical Endocrinology and Metabolism·P J Snyder, D A Lawrence
Nov 1, 1996·British Journal of Urology·L J Gooren
Jun 1, 1997·The Journal of Clinical Endocrinology and Metabolism·R SihC Ross
Nov 14, 1997·The Journal of Clinical Endocrinology and Metabolism·R R HajjarJ E Morley
Feb 7, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·G A GreendaleE Barrett-Connor
Feb 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T ShaneyfeltC S Mantzoros
Oct 4, 2000·Metabolism: Clinical and Experimental·J E MorleyH M Perry
Aug 14, 2003·The Journal of Clinical Endocrinology and Metabolism·Peter Y LiuDavid J Handelsman
Jan 30, 2004·The New England Journal of Medicine·Ernani Luis Rhoden, Abraham Morgentaler
May 8, 2004·Metabolism: Clinical and Experimental·J J CorralesJ M Miralles
Oct 27, 2004·Expert Opinion on Drug Safety·R S Tan, J A Salazar
Jul 12, 2005·Revista da Associação Médica Brasileira·Anna Maria Martits, Elaine Maria Frade Costa
Aug 10, 2005·Expert Opinion on Pharmacotherapy·Lindsey HarleAdrian S Dobs
May 25, 2006·The Journal of Clinical Endocrinology and Metabolism·Shalender BhasinVictor M Montori
Nov 9, 2006·The Journal of Clinical Endocrinology and Metabolism·William RosnerHershel Raff
Jul 25, 2007·The Journal of Sexual Medicine·Han M Hanafy
Jul 18, 2008·International Journal of Impotence Research·R ShabsighK M Slawin
Feb 7, 2009·Arquivos brasileiros de endocrinologia e metabologia·Ruth ClapauchIsabel Pessoa
Feb 7, 2009·Arquivos brasileiros de endocrinologia e metabologia·Ruth ClapauchYolanda Schrank

❮ Previous
Next ❯

Citations

Aug 10, 2017·Journal of the American Animal Hospital Association·Jean-Sébastien PalermeShelly L Vaden
Oct 17, 2019·Frontiers in Endocrinology·Daniel Pantoja EstumanoMoisés Hamoy
Feb 1, 2019·Journal of Clinical Medicine·Min Gu ParkDu Geon Moon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revista da Associação Médica Brasileira
Anna Maria Martits, Elaine Maria Frade Costa
La Clinica terapeutica
A MARINOSCI, A D PERUZY
Sovetskaia meditsina
P A Sil'nitskiĭ
La Clinica terapeutica
F D Regno
© 2021 Meta ULC. All rights reserved